News, info and tips for living with multiple sclerosis
It’s been a month since I last posted here. I’m sorry. I’ve been spending my time riding a roller coaster. It’s the roller coaster of reactions that I was told to expect following my Lemtrada infusions. I managed to avoid most of those reactions for the first month and I thought that I was home free. Ha! What could I have been thinking? Month-two began with a good lab report…Continue Reading
It’s no fun jabbing yourself once-a-day if you’re using the multiple sclerosis drug Copaxone. I, eventually, hit a brick wall self-injecting when I was using Avonex and that was just sticking myself once-a-week. But now Teva Pharmaceutical has what should be good news for Canadians using Copaxone. Health Canada has approved a three-times-a-week version of the drug. Three-times-a-week Copaxome 40 mg/mL is expected to become available to patients there, by…Continue Reading
It had been hoped that Biogen’s experimental drug opicinumab would be able to repair mylin. As those of us who live with Multiple Sclerosis know all too well, mylin is sort of an insulator to our nerves. MS destroys mylin and, in doing so, short circuits our nervous system. Biogen announced today that Phase 2 of its opicinumab trial, named SYNERGY, failed to meet its primary goal of improving physical…Continue Reading
Could an over-the-counter drug, used to treat sniffles, help ease M.S. symptoms and maybe even repair myelin? Maybe…someday. The drug is clemastine fumarate, a common antihistamine used to treat cold and allergy symptoms. In a small, preliminary study involving M.S. and optic neuropathy, (damage to the nerve that sends info from the eye to the brain), participants who took clemastine fumarate showed what the study terms a “modest” improvement in…Continue Reading